ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,626.02
      0.54%
      US Tech 100
      18,986.40
      0.30%
      Dow Jones
      41,393.78
      0.72%
      Brent Oil
      71.825
      0.00%
      Bitcoin
      60,003.47
      -0.01%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Lyra Therapeutics Inc (LYRA) Quote

      Lyra Therapeutics Inc

      Lyra Therapeutics Inc (LYRA)

      NASDAQ
      0.28
      0.02
      (7.69%)
      Closed September 15 4:00PM
      Delayed by 15 minutes
      0.272
      -0.008
      (-2.86%)
      After Hours: 7:47PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.272
      Bid
      0.275
      Ask
      0.2799
      Volume
      848,664
      0.2599 Day's Range 0.3079
      0.2532 52 Week Range 9.98
      Market Cap
      17.804M
      Previous Close
      0.26
      Open
      0.261
      Last Trade
      100
      @
      0.272
      (formt)
      Last Trade Time
      Financial Volume
      $ 229,633
      VWAP
      0.270582
      Average Volume (3m)
      2,315,830
      Shares Outstanding
      65,456,735
      Dividend Yield
      -
      PE Ratio
      -0.29
      Earnings Per Share (EPS)
      -0.96
      Revenue
      1.56M
      Net Profit
      -62.68M

      About Lyra Therapeutics Inc

      Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precis... Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      lyratherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Lyra Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LYRA. The last closing price for Lyra Therapeutics was $0.26. Over the last year, Lyra Therapeutics shares have traded in a share price range of $ 0.2532 to $ 9.98.

      Lyra Therapeutics currently has 65,456,735 shares outstanding. The market capitalization of Lyra Therapeutics is $17.02 million. Lyra Therapeutics has a price to earnings ratio (PE ratio) of -0.29.

      Ask ADVFN Intelligence (AI)

      LYRA Latest News

      More News

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 14 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 14 2024
      Edgar (US Regulatory)

      Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

      – Primary focus continues to be on upcoming results from ENLIGHTEN 1 Phase 3 extension study in 4Q 2024 and ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients in 1H 2025, as planned – – In...

      August 14 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      July 23 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 18 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 14 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 14 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 14 2024
      Edgar (US Regulatory)

      Form 8-K/A - Current report: [Amend]

      June 07 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      May 21 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.024-8.108108108110.2960.34260.25468503700.304204CS
      40.01023.89610389610.26180.3440.253212876700.29104355CS
      12-5.958-95.63402889256.236.790.253223158300.69928467CS
      26-4.308-94.06113537124.586.790.253212949751.05940438CS
      52-8.208-96.79245283028.489.980.25325057611.58598963CS
      156-20.728-98.704761904821220.25323798272.49411821CS
      2600000.3079000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NOVVUNova Vision Acquisition Corporation
      $ 41.00
      (207.35%)
      		17.4k
      NOVVNova Vision Acquisition Corporation
      $ 37.0001
      (200.08%)
      		205.22k
      SMXSMX Security Matters Public Company
      $ 5.85
      (138.78%)
      		50.1M
      OMICSingular Genomics Systems Inc
      $ 12.38
      (119.12%)
      		2.87M
      TILInstill Bio Inc
      $ 84.75
      (82.41%)
      		3.91M
      GSIWGarden Stage Ltd
      $ 2.9693
      (-75.66%)
      		4.21M
      UPCUniverse Pharmaceuticals Inc
      $ 0.55
      (-67.07%)
      		29.83M
      VMARVision Marine Technologies Inc
      $ 0.77
      (-48.67%)
      		30.61M
      PRLDPrelude Therapeutics Inc
      $ 2.775
      (-42.55%)
      		2.49M
      CNEYCN Energy Group Inc
      $ 0.4335
      (-37.17%)
      		4.79M
      NVDANVIDIA Corporation
      $ 119.10
      (-0.03%)
      		238.43M
      XXII22nd Century Group Inc
      $ 0.3447
      (28.00%)
      		183.73M
      IMRXImmuneering Corporation
      $ 2.02
      (41.26%)
      		136.36M
      SQQQProShares UltraPro Short QQQ
      $ 8.17
      (-1.33%)
      		127.78M
      MULNMullen Automotive Inc
      $ 0.1328
      (-20.48%)
      		120.81M

      LYRA Discussion

      View Posts
      Dennis14 Dennis14 1 month ago
      Earnings out.
      👍️0
      Dennis14 Dennis14 1 month ago
      Big buys after hours 86000 buy and (3)50000 buys
      👍️0
      Dennis14 Dennis14 1 month ago
      It now says 13th after hours. We will see
      👍️0
      Dennis14 Dennis14 1 month ago
      Earnings supposed to be on the 12th Aug.
      👍️0
      Dennis14 Dennis14 2 months ago
      I just read. Earnings coming out next week or the week after.
      👍️0
      Dennis14 Dennis14 2 months ago
      Earnings coming out any day now.
      👍️0
      BigBadWolf BigBadWolf 3 months ago
      DDAmanda finds them early so that Han's (he provided the name pumping testimonials) can sell off his early buys while he's pumping to his paid subscribers. Want proof DDAmanda $subscribers PM me for verification or simply check my posting history for the mud this P_G waddles in..
      https://lyratherapeutics.com/
      👍️0
      Zardiw Zardiw 3 months ago
      Well, 6 weeks ago she was $5: $LYRA Chart from #DDAmanda - #1 Stock Screener :

      Find Winners Early:



      Z
      👍️0
      Termite7 Termite7 3 months ago
      Who? .....How high for LYRA? .......Thanks!!!
      👍️0
      Zardiw Zardiw 3 months ago
      Nice list.........$LYRA is due.......according to #DDAmanda.

      Z
      👍️0
      Termite7 Termite7 3 months ago
      Oversold!!! ......https://finviz.com/screener.ashx?v=110&s=ta_oversold&o=change
      👍️0
      Zardiw Zardiw 4 months ago
      $LYRA Book Value is $1.27 ......trading at .34 ........or 1/4 the BV........

      Z
      👍️ 1
      INV4 INV4 4 months ago
      LYRA Institutional Holdings
      Ownership Summary

      Institutional Ownership • 74.73%
      Total Shares Outstanding (millions) • 61
      Total Value of Holdings (millions) • $16

      Active Positions • Holders • Shares
      Increased Positions • 54 • 9,224,767
      Decreased Positions • 19 • 6,026,566
      Held Positions • 11 • 30,304,888

      Institutional Holders: 84
      Total Shares Held: 45,556,221

      $BLEG

      LYRA Analyst Research
      Lyra Therapeutics, Inc. Common Stock (LYRA) Analyst Research
      LYRA Earnings Consensus

      CONSENSUS
      Buy
      Based on 6 analysts offering recommendations for 'LYRA'.

      Analyst Price Targets
      CONSENSUS
      $0.95

      Based on analysts offering 12 month price targets for LYRA in the last 3 months.
      The average price target is $0.95 with a high estimate of $2 and a low estimate of $0.35.

      https://www.nasdaq.com/market-activity/stocks/lyra/analyst-research

      $LYRA
      👍️0
      Zardiw Zardiw 4 months ago
      $LYRA Bounce anytime now...............

      Z
      👍️ 1
      INV4 INV4 4 months ago
      Let's see when it bounces 😀

      $LYRA
      👍️0
      glenn1919 glenn1919 4 months ago
      LYRA.........................................https://stockcharts.com/h-sc/ui?s=LYRA&p=W&b=5&g=0&id=p86431144783
      👍️0
      Zardiw Zardiw 4 months ago
      Yes. Expecting a nice $LYRA Bounce..............

      Z
      👍️0
      Dennis14 Dennis14 4 months ago
      Relative Strength Index is at 12 this is way over sold.
      👍️0
      Zardiw Zardiw 4 months ago
      $LYRA Book Value: $1.28 ....currently at .43 ...

      Z
      👍️0
      Dennis14 Dennis14 4 months ago
      Bought in this morning at .42, I believe this will be back to at least 1 or 2 bucks.
      👍️0
      axelvento axelvento 4 months ago
      game over: announced topline results from the Phase 3 ENLIGHTEN 1 trial evaluating LYR-210 for the treatment of chronic rhinosinusitis (CRS). ENLIGHTEN 1 did not meet its primary endpoint
      👍️0
      Monksdream Monksdream 5 months ago
      LYRA under $10

      👍️0
      Monksdream Monksdream 6 months ago
      LYRA under $10
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      LYRA...NOT HOLDING INTO ER
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      LYRA...LETS SEE 7.00
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      LYRA...EXPLODING!!!!!
      👍️0
      Monksdream Monksdream 6 months ago
      LYRA 10Q due March 14
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      LYRA...BEAUTIFUL BREAK OUT
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      LYRA....BIO BEAST!
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      LYRA...HERE WE GO
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      LYRA...MOVES ON AIR!!!
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      LYRA...HERE WE GO
      👍️0
      Monksdream Monksdream 6 months ago
      LYRA 10Q due March 7
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      LYRA..WHAT A BEAUTY...NOBODY TALKING!!!
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      LYRA...NEXT BIO BEAST READY TO BEAST
      👍️0
      Monksdream Monksdream 1 year ago
      LYRA No 3 on the Barchart Top 10
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0

      Your Recent History

      NASDAQ
      LYRA
      Lyra Therapeutics
      Delayed Upgrade Clock